Excitement is building as the fourth iteration of the Good Publication Practice (also known as GPP4) guidance nears completion.

At the 2022 European Meeting of ISMPP in late January, Dan Bridges (CEO, Nucleus Global) of the GPP4 Steering Committee presented information on the team’s progress.

Watch the video below to view this GPP4 update, which:

  • Outlines the overall process for drafting GPP4, emphasizing the expert review and peer-review steps
  • Highlights the new areas of focus in GPP4, including social media posting about publications, including patients in publications planning and authoring, enhanced content, and subject matter beyond the clinical trial
  • Shares the Steering Committee’s plans for the 18th Annual Meeting of ISMPP, May 9-11, 2022, in Washington, DC

GPP4 Steering Committee

Lise Baltzer (Novo Nordisk A/S)
Dan Bridges (Nucleus Global)
Leslie Citrome (New York Medical College)
Lisa DeTora (Hofstra University)
Faith DiBiasi (Otsuka Pharmaceuticals)
Laura Dormer (Future Science Group)
Eline Hanekamp (Excerpta Medica)
Trevor Lane (Edanz Group Ltd.)
Angela Sykes (Pfizer)
Dikran Toroser (Takeda)
Christine Vanderlinden (GSK Biologicals)

%d bloggers like this: